|
|
Champions Biotechnology, Inc. - Comparative Business Analysis Snapshot
Business Description
Champions Biotechnology, Inc.. The Group's principal activity is the development of advanced preclinical platforms and predictive tumor specific data to enhance and accelerate the value of oncology drugs. Its preclinical platform is a novel approach based upon the implantation of primary human tumors in immune deficient mice followed by propagation of the resulting xenografts in a manner that preserves the biological characteristics of the original human tumor. The Group operates in the United States.
Competitor Analysis
This analysis compares Champions Biotechnology, Inc. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
